We talked about the same thing we talked about last year (safe sharps disposal for GLP-1 patients) except this time I had data to back up everything that surprised me the first time around
Retatrutide is still being evaluated in clinical trials, where researchers are studying its safety, effectiveness, and long-term outcomes
The 28-week Precose Resolution of Optimal Titration to Enhance Current Therapies (PROTECT) trial, which followed more than 6,000 patients with type 2 diabetes in a real-world setting, concluded that acarbose has an excellent safety profile irrespective of patients' age, weight, ethnicity, the time since their diagnosis and the presence or absence of concomitant therapy [65]
This is especially important for women with PCOS who are managing insulin resistance
(29) Female mice were fed a high-fat diet to induce obesity and type 2 diabetes before being treated with semaglutide (10 nmol/kg) or insulin (0.5 U/kg) for up to 28 days
Similarly, FDA sent a warning letter to Greek drugmaker Pharmathen International for CGMP violations